Maternal body composition can be an important determinant for development of obesity and metabolic syndrome in adult offspring. Obesity-related outcomes in offspring may include epigenetic alterations; however, mechanisms of fetal programming remain to be fully elucidated. This study was conducted to determine the impact of maternal obesity in the absence of a high fat diet on equine endometrium and preimplantation embryos. Embryos were collected from normal and obese mares at 8 and 16 days and a uterine biopsy at 16 days (0 day = ovulation). With the exception of 8 day embryos, each sample was divided into two pieces. One piece was analyzed for gene expression markers related to carbohydrate metabolism, lipid homeostasis, inflammation, endoplasmic reticulum stress, oxidative stress, mitochondrial stress, and components of the insulin-like growth factor (IGF) system. The second piece was analyzed for lipid content using matrix-assisted laser desorption/ionization mass spectrometry. Obese mares had elevated concentrations of insulin, leptin, and total cholesterol, and they tended to have increased triglycerides and decreased insulin sensitivity. Embryos from obese mares had altered transcript abundance in genes for inflammation and lipid homeostasis, as well as endoplasmic reticulum, oxidative and mitochondrial stress and altered lipid fingerprints. Endometrium from obese mares had increased expression of inflammatory cytokines, lipid homeostasis regulation, mitochondrial stress, and the IGF2 system. This study demonstrates that increased adiposity in mares alters the uterine environment, transcript abundance of genes for cellular functions, and lipid profiles of embryos. These alterations could affect prenatal programming, with potential long-term effects in offspring.
Introduction
In many species, maternal diet and body composition are important determinants for the development of obesity and metabolic syndrome in their adult offspring. Obesity-related outcomes in offspring could be "programmed" and include epigenetic alterations; however, when and how maternal weight affects the gamete, embryo, fetus, or offspring is still to be determined. Mechanisms associated with fetal programming are not fully elucidated and are probably multifactorial. In rats, maternal obesity in the absence of diabetes leads to changes in the uterine and embryonic transcriptome, including upregulation of proinflammatory pathways and ectopic lipid accumulation in the uterine endometrium that is associated with lipotoxic pathways [1] . Lipid metabolism pathways are altered in blastocysts from overweight mice and are consistent with observations in adult animals with metabolic disruptions [2] .
When compared to normal-weight horses, obesity alters the lipid content of oocytes, with a reduction in lipids associated with membrane function (phosphatidylcholines, phosphatidylethanolamines, and sphingomyelins) and an increase in triglycerides [3] . The elevated concentrations of triglyceride species in oocytes from obese mares could contribute to elevated lipids in early embryos and result in oxidative stress and/or long-term effects on metabolism. Exposing in vitro produced bovine embryos to hyperlipidemic conditions results in blastocysts with increased fatty acids and of lower quality [4, 5] . At 70 days of gestation, the resulting fetuses have lower body weights, reduced liver weights, and an increased crown-rump length to weight ratio, suggesting an influence on fetal development [4] . In several species, low fetal weight and low birth weight are associated with offspring with lasting implications including development of metabolic disorders as an adult [6] .
In mares, increased body condition scores (BCS) and percentage of body fat are associated with an increase in the transcript abundance of inflammatory cytokines, tumor necrosis factor-α (TNFα) and IL-1, and concentrations of TNFα protein in whole blood [7] . While inflammatory cytokines are involved in the normal implantation process in many species, an excess of these cytokines is detrimental (for review [8] ). However, the equine embryo does not implant into the uterine endometrium, instead on approximately D16 of gestation, increased uterine tone and the enlarged embryo causes the embryo to become stationary in a uterine horn, a process called fixation [9] and the role of cytokines in that process is unknown. Bovine embryos that were biopsied prior to transfer into recipients and did not result in a pregnancy had elevated expression of TNFα compared to those embryos that did result in pregnancy [10] indicating a role in embryonic loss.
Maternal obesity is also associated with markers of oxidative stress, and reactive oxygen species production can precede the onset of obesity in response to maternal nutrition in the human placenta [11] . In mice, oxidative stress is also associated with endoplasmic reticulum (ER) stress and mitochondrial dysfunction. Mitochondrial dysfunction has been reported as early as embryogenesis in obese mothers, with these embryos having increased mitochondrial membrane potential, higher levels of oxidative phosphorylation, and increased reactive oxygen species production [12] .
Another important system in embryo development is the insulinlike growth factor (IGF) system. In mice, insulin-like growth factor receptor 1 (IGFR1) is critical to normal insulin signaling and glucose transport in preimplantation blastocysts [13] ; additionally, IGF receptor 2 (IGFR2) is known to influence placental and fetal size [14] . Placental tissue from obese offspring in mice had 3-fold higher expression of IGFR2 at mid-gestation [15] .
The disruption in expression of genes responsible for metabolism, lipid homeostasis, and inflammation could be occurring through changes in DNA methylation. Obesity results in changes of DNA methylation in blood leukocytes of humans [16] and in adipose and muscle tissues of pigs [17] . Maternal nutritional status during early pregnancy results in persistent and systemic epigenetic changes at metastable epi-alleles in human offspring [18] ; however, the relationship between obesity and alterations in DNA methylation in uteri and embryos remains unknown.
The present study was conducted to determine the impact of maternal obesity, in the absence of a high fat diet, on the equine endometrium and at two stages of embryo development, blastocysts with minimal exposure to the uterine environment and D16 embryonic vesicles that have completed transuterine migration. We hypothesized that maternal body condition would have an impact on both embryos that had minimal exposure to the uterine environment and those that had been exposed to the uterus for approximately 1 week. Our objectives were to make comparisons between embryos from mares with normal or obese body condition in regard to (1) lipid fingerprints, (2) changes in global DNA methylation, and (3) expression of genes involved in carbohydrate metabolism, lipid homeostasis inflammation, ER stress, oxidative stress, mitochondrial stress, and IGF system. We also hypothesized that maternal obesity would impact the metabolic profile and gene expression in the uterine endometrium.
Materials and methods

Mare management and sample collections
The experiment was conducted late July through early October at 40.5592 • N, 105.0781
• W. All animal procedures were performed in accordance with the Institutional Animal Care and Use Committee at Colorado State University. Light-horse mares of similar type and 8-16 years of age and with normal (n = 9) or obese (n = 6) body conditions were used. Mares were classified as "Obese" according to four criteria: BCS of ≥7.0 on a scale from 1 (emaciated) to 9 (extreme obesity) [19] , percent body fat of ≥10%, girth: height of ≥1.27, and neck circumference: height of ≥0.63 [20] . Mares classified as "Normal" had a BCS of 4.25-5.5, percent body fat of <10%, girth: height of ≤1.26, and neck circumference: height of <0.62. Mares were grouped in adjacent dry lots with ad libitum access to water. Normal-weight mares were fed 6.8-9.1 kg (15-20 lbs) of hay, with an approximately 60 to 40% mix of grass and alfalfa. The amount of hay was adjusted as needed during the study to maintain consistent body conditions. Obese mares had ad libitum access to the same hay. Mares were used for multiple cycles to collect early embryos at 7-8 days after ovulation (D8) for lipid evaluation, D8 embryos for gene expression analysis, and an embryo and uterine biopsy at 16 days (D16) after ovulation. One to three embryos were collected from individual mares, but only one embryo per mare was used for each type of evaluation. For D8 embryo collections, mares' reproductive tracts were examined using transrectal ultrasonography. When a growing follicle ≥35 mm in diameter and uterine edema were imaged, a GnRH analog (deslorelin acetate, 1.5 mg, IM, Precision Pharmacy, Bakersfield, CA) was administered to induce ovulation. Mares were inseminated the following day with fresh or cooled semen (5 × 10 6 to 10 × 10 6 progressively motile sperm) from a single stallion of normal body condition and good fertility. Reproductive tracts of the mares were scanned daily until ovulation. At 7 or 8 days after the detection of ovulation, D8 embryos were collected by uterine lavage with lactated Ringer's solution supplemented with 0.02% polyvinyl alcohol (Sigma, St Louis, MO). Images of D8 embryos were taken using a Nikon Digital Sight Vi1 camera on a Nikon Eclipse Ti microscope (Nikon Instruments, Inc, Mellville, NY) and used to determine embryo diameters. After embryo collections attempts, prostaglandin (Estrumate, 1.0 ml, IM, Merck Animal Health, Whitehouse Station, NJ) was administered to lyse the corpus luteum and shorten the interval to the subsequent follicular phase. Day 8 embryos from Normal (n = 5) and Obese (n = 5) were stored in a 50% methanol solution (molecular grade water/methanol, 50/50, v/v) at -20
• C for analysis using matrixassisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF-MS) to determine the lipid fingerprint of individual embryos. A second set of D8 embryos were collected from Normal (n = 4) and Obese (n = 4), saved in Lysis Solution (RNAqueous micro RNA isolation, Life Technologies, Grand Island, NY), and stored at -80
For D16 embryo collections, mares were managed as described above with exception of when a growing follicle ≥35 mm and uterine edema was observed during the follicular phase, mares were inseminated every other day until ovulation with 5 × 10 6 to 10 × 10 6 of fresh or cooled progressively motile sperm from the same stallion as used for inseminations for D8. Twelve days after ovulation, mares' uteri were examined by ultrasonography for pregnancy determination. Pregnant mares were evaluated again at 16 days to determine the diameter and location of the embryonic vesicle within the uterus. A uterine biopsy was collected using uterine biopsy forceps (60 cm, Jorgensen Labs, Loveland, CO) from the uterine horn contralateral to the location of the embryonic vesicle. Uterine biopsies were dissected into two parts, and each section was snap frozen in liquid nitrogen and stored at -80
• C for metabolite, gene expression, and global DNA methylation evaluations. For collections, D16 embryonic vesicles were imaged using ultrasound while a uterine lavage was conducted using a 40 Fr catheter (Mila International, Erlanger, KY) and the same lavage solution as for D8. While imaged with a stereoscope (20X eyepieces, Nikon SMZ1500, Nikon Instruments Inc, Mellville, NY), embryonic discs were dissected from embryonic membranes, which are referred to within this manuscript as trophectoderm, although the membranes probably incorporated other germ cell layers. The central portion of the embryonic disc was placed in 50% methanol and stored at -20
The ends of the embryonic disc were placed in buffer RLT (Allprep DNA/RNA/Protein isolation kit, Qiagen, Valencia, CA), snap frozen in liquid nitrogen, and stored at -80 • C until RT-PCR and global DNA methylation analysis. The trophectoderm was separated into two pieces: one placed in 50% methanol and stored at -20
for MALDI-MS analysis, and the other placed in buffer RLT, snap frozen in liquid nitrogen, and stored at -80
• C until later analysis for gene expression and DNA methylation. An embryonic vesicle from a normal mare was torn at collection, and no embryonic disc could be identified. Another embryo from a normal mare was an undersized, intact embryo with no apparent embryonic disc; therefore, the embryo was not included in the experiment, and a subsequent embryo was collected and used for that mare. On embryo collection days, blood (8 ml) was collected by jugular venipuncture into tubes with no additive for serum and with EDTA for plasma (Vacutainer, Becton, Dickinson and Company, Franklin Lakes, NJ). Blood glucose from whole blood was determined at this time using a hand-held glucose meter (Accutrend Plus, Roche Applied Science, Indianapolis, IN). Blood samples were stored at room temperature for 30 min before centrifugation at 2000 × g for 10 min. Serum and plasma were placed into multiple 2-ml aliquots and stored at -20
• C until analysis for insulin, leptin, adiponectin, 
Blood sample analysis
Serum insulin concentrations were determined using a validated radioimmunoassay (RIA, Coat-A-Count, Siemens Healthcare, Erlangen, Germany) as previously reported [22] . The intra-assay coefficient of variation of the pooled samples was 9.1%, and the limit of detection was 1.9 μIU/ml. Serum concentrations of leptin were determined according to the manufacturer's protocol using an RIA (MultiSpecies Leptin RIA, Millipore Corp, Billerica, MA) previously validated for use in equine serum [23] . In the absence of purified equine leptin, results are expressed as human equivalents of immunoreactive leptin (leptin-HE). The intra-assay coefficient of variation of the assay was 9.9%. The limit of detection for the assay was 1.0 ng/ml. Concentrations of adiponectin in serum were determined according to manufacturer's protocol using an RIA (Human Adiponectin RIA, Millipore Corp) previously validated for use in equine plasma [24] .
In the absence of purified equine adiponectin, results were expressed as human equivalents of immunoreactive adiponectin (adiponectin-HE). The intra-assay coefficient of variation of the assay was 5.4%, and the limit of detection was 0.8 ng/ml. Triglyceride concentrations in plasma were determined using a colorimetric assay kit (Cayman Chemicals, Ann Arbor, MI) according to manufacturer's instructions. The 96-well microplate (Thermo Fisher Scientific, Waltham, MA) was read at 540 nm absorbance on a Synergy 2 plate reader (Biotek, Winooski, VT). The intra-assay coefficient of variation of the pooled samples was 0.9%, and the limit of detection was 3.1 mg/dL.
Concentrations of high density lipoprotein (HDL) and very low density lipoprotein (VLDL)/low density lipoprotein (LDL) cholesterol in serum were determined using a fluorometric HDL and LDL/VLDL Cholesterol Assay Kit (Cell Biolabs, Inc, San Diego, CA) according to the manufacturer's instructions with the modification of the emission reading. The assay was read at an excitation of 540 nm and emission of 620 nm on a Synergy 2 plate reader. The intra-assay coefficient of variation of the pooled samples was 2.2%, and the limit of detection was 1.0 mg/dL.
RNA isolation, DNA methylation, and gene expression analysis
Total RNA from early embryos was isolated using the RNAqueous micro RNA isolation kit according to manufacturer's protocol. Total RNA and genomic DNA from endometrium and D16 embryonic discs and trophectoderm were isolated using the AllPrep RNA/DNA/Protein Kit per instructions. Following isolation, the RNA fractions were treated with DNAse (Invitrogen, Carlsbad, CA) to prevent contamination with residual genomic DNA. Primers for the genes relating to carbohydrate metabolism, inflammation, metabolism, lipid homeostasis, ER stress, oxidative stress, mitochondrial stress, IGF system, and endogenous reference genes were designed using predicted sequences for the horse (Supplementary Table S1 ) [3, 25] . Complementary DNA was generated using the qScript cDNA synthesis kit (Quanta Bioscience, Gaithersburg, MD) with both oligo (dT) and random primers. Real-time PCR was performed using the LightCycler 480 II Real-Time PCR System and the LightCycler 480 SYBER Green I Master detection reagents (Roche Applied Science, Indianapolis, IN). For each sample, all genes were analyzed simultaneously in duplicate. No template controls were included on each plate for each primer set. For samples from D16 trophectoderm, embryonic discs, and endometrium, 12.5 ng cDNA was used per reaction. Fewer targets were analyzed in the embryonic disc samples because of lower mRNA quantity. For D8 embryos with lower mRNA abundance, genes for carbohydrate metabolism, inflammation, metabolism, and lipid homeostasis were analyzed, using 5.0 ng cDNA per reaction. All qPCR reactions were run at 95
• C for 5 min, followed by 45 cycles of 95
• C for 10 s, 60
• C for 30 s, and 72
• C for 30 s. Products of qPCR were analyzed on an agarose gel with ethidium bromide to confirm specificity based on fragment size. DNA was isolated from the gel (QAIquick PCR Purification Kit, Qiagen) and sequenced to confirm amplification of the genes of interest (DNA Sequencing Facility, University of California-Davis). Data were analyzed by the LightCycler 480 Relative Quantification Software (Roche Applied Science) and normalized to the geometric mean of the two endogenous controls (GAPDH and TUBA1A), and melting curves for each sample were analyzed to validate specificity of amplification. Global DNA methylation was assessed using isolated genomic DNA from endometrium, D16 embryonic disc, and D16 trophectoderm. Analysis was completed using the MethylFlash Methylated DNA Quantification kit Methylation kit (Epigentek, Farmingdale, NY) and the MethylFlash Hydroxymethylated DNA Quantification Kit (Epigentek) according to the manufacturer's instructions. Assays were read on a Victor X5 plate reader (Perkin-Elmer, Waltham, MA) at 450 nm absorbance.
Lipid fingerprinting using MALDI-MS and GC-MS profiling of uterine tissue
Lipid fingerprinting was performed using MALDI-TOF-MS based on methods previously described [26] . Briefly, samples were taken directly from the 50% methanol storage solution, spotted on an MTP 384 stainless steel MALDI target plate (Bruker Daltonics, Bremen, Germany), and allowed to dry. Dried samples were layered with 1 μl of 2,5-dihydroxybenzoic acid (DHB; 10 mg/ml in 50% acetonitrile, 0.1% trifluoracetic acid) prior to analysis. Mass spectrometry analysis was performed on a Bruker Ultraflex II MALDI-TOF/TOF (Bruker Daltonics). Acquisition was performed in positive ion reflector mode with a 25 kV acceleration voltage, using a mass window of 100-2100 m/z. External calibration was performed using the Bruker peptide calibration standard II that was co-spotted with DHB matrix. Each sample was analyzed until no further data could be collected without dramatically increasing the laser power. Peak detection, baseline subtraction, alignment, and quantitation of the MS data were performed using the PROcess package in the R statistical environment [27, 28] , and data were normalized to total ion signal. Lipids were annotated using accurate mass, specifically values of [M + H] + or [M + Na] + adducts to the metabolite databases,
Metlin [29] and LipidMaps [30] , with a ppm error threshold of 30 or less, and are considered level 2 identifications as described by the Metabolomics Standards Initiative [31] . Uterine tissue (n = 5 biological replicates for Normal and Obese) was ground using a Bullet Blender bead beating system (Next Advance, Averill Park, NY) in 1 ml of methanol: water (70/30, v/v). The extract was dried via speedvac, derivatized, and metabolites were detected, processed, and annotated using gas chromatography-mass spectrometry metabolomics (GC-MS) as previously described [3] .
Statistics
Insulin sensitivity; concentrations of insulin, adiponectin, leptin, glucose, triglycerides, and cholesterol; and embryo diameters from Normal and Obese were compared using the Student t-test (SigmaPlot, Systat Software Inc., San Jose, CA). Relative gene expression and global DNA methylation of embryonic discs, trophectoderm, and endometrium from D16 samples and relative gene expression between D8 embryos from Normal and Obese were analyzed using the Student t-test (SigmaPlot). Data that failed the Shapiro-Wilk test for normality were log-transformed to normalize the data set prior to analysis. For analysis of lipid composition determined by MALDI-MS, each spectral peak was normalized to the total ion signal, and relative lipid concentrations were compared using the Student t-test (Excel, Microsoft Corporation, Redmond, WA). Uterine metabolites detected by GC-MS were normalized to the total ion current and values were compared via the Student t-test. Data are presented as mean ± SEM. Significance was set at P < 0.05, with tendencies reported for 0.05 ≤ P ≤ 0.10.
Results
Mare hormone and metabolite analyses and embryo diameters
When compared to Normal, Obese had elevated serum concentrations of leptin (P = 0.02) and total cholesterol (P = 0.03) and tended to have elevated serum insulin (P = 0.06) and plasma triglycerides (P = 0.1) ( Table 1) . When compared to Normal, Obese were insulin resistant based on two proxy analyses, MIRG (P = 0.05) and RISQI (P = 0.06). Diameters of embryos collected from Normal and Obese at D8 (276.9 ± 81.8 vs. 238.6 ± 39.0, respectively, relative pixel number) and D16 (24.5 ± 2.2 vs. 29.0 ± 1.8 mm, respectively; measured from ultrasound images) were similar (P = 0.14) and did not have any differences in developmental stage.
Gene expression and DNA methylation
Early embryos (D8) from Obese tended to have increased expression of fatty acid synthase (FASN, P = 0.10) and decreased expression of interleukin-1β (IL1B, P = 0.06) when compared to D8 embryos from Normal. No other genes were different between the groups (Table 2) . When compared to Normal, D16 embryonic discs from Obese had increased expression of adiponectin receptor 2 (ADI-POR2, P = 0.05) and decreased expression of cluster of differentiation 36 (CD36, P = 0.01). No other genes were different between the groups (Table 3) . Trophectoderm from D16 Obese had increased expression of FASN (P = 0.03), long-chain fatty acid transport protein 1 (SLC27A1, P = 0.03), glutaredox-1 (GPX1, P = 0.02), and thioredoxin (TXN2, P = 0.003). DNA damage-inducible transcript (DDIT3, P = 0.08) and thioredoxin-dependent peroxide reductase (PRDX, P = 0.08) tended to be elevated in trophectoderm from Obese. Trophectoderm from Obese had decreased expression of CD36 (P = 0.002) when compared to Normal as observed in embryonic discs. Interleukin-6 signal transducer (IL6ST, P = 0.02) expression was lower and interleukin-1 receptor accessory protein (IL1RAP, P = 0.08) tended to be lower than trophectoderm from Normal. Expression of other genes was similar (Table 4) . Values in bold are different (P < 0.05) or tend to be different (P ≤ 0.1). Values in bold are different (P < 0.05) or tend to be different (P < 0.1). The correction factor indicates expression at 10 X . * Data were log-transformed for analysis.
Endometrium from Obese had increased expression of leptin receptor (LEPR, P = 0.05), TNFα (P = 0.02), IL1B (P = 0.006), and activating transcription factor-6 (ATF6, P = 0.04), and tended (P = 0.07) to have increased perilipin-2 (PLIN2) expression. Endometrium from Obese had decreased expression of nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha (NFKBIA, P < 0.001), IGF2 (P = 0.009), and IGFR2 (P = 0.003) and tended to have decreased expression of lactate dehydrogenase A (LDHA, P = 0.08) and peroxisome proliferator-activated receptor gamma (PPARG, P = 0.1, Table 5 ). Values in bold are different (P < 0.05) or tend to be different (P ≤ 0.1). The correction factor indicates expression at 10 X . * Data were log-transformed for analyses.
Embryonic discs from Normal (0.050 ± 0.01%) tended to have higher global hydroxymethylated DNA compared to embryonic discs from Obese (0.031 ± 0.003%; P = 0.08). There were no other differences in global methylated or hydroxymethylated DNA between the embryonic discs and trophectoderm from D16 embryos or endometrium of Normal and Obese.
Lipid content of embryos and metabolite content of uterine endometrium
Day 8 embryos from Obese had altered lipid fingerprints when compared to those from Normal ( Figure 1A) . Specifically, 14 lipid species were significantly increased in embryos from Normal, and another 11 tended to be higher. These lipids had mass peaks corresponding to phosphatidic acid (PA), glycerophosphocholine (PC), glycerophosphoethanolamine (PE), glycerophophatidylinositol (PI), phosphatidylglycerol (PG), phosphatidylserine (PS), phosphatidylinositol phosphate (PIP), and cytidine diphosphate diacylglycerol (CDP-DG). Embryos from Obese tended to have an elevated lysoPG (Supplementary Table S2 ). Additional mass peaks were significantly elevated (n = 16) or tended to be elevated (n = 21) in Normal, but they were not identified. Embryos from Obese had three mass peak species that were significantly elevated (n = 3) or tended (n = 4) to be elevated when compared to Normal with an additional four that tended to be higher (Supplementary Table S5 ).
In D16 embryos, embryonic discs ( Figure 1B ) had more alterations in lipid profiles than trophectoderm ( Figure 1C ). Fifteen lipids corresponding to PA, PC, PE, PI, PG, PS, PIP, CDP-DG, and triglyceride were elevated in embryonic discs from Normal vs Obese with an additional eight that tended to be higher (Supplementary  Table S3 ). Embryonic discs from Obese had an elevated PA when compared to Normal. An additional 10 unidentified mass peaks were higher in embryonic discs from Normal compared to 3 that were elevated in samples from Obese (Supplementary Table S5 ). Trophectoderm from Normal had a LysoPG that was elevated when compared to Obese. An additional five mass peaks corresponding to PC, PA, PI, and CDP-DG tended to be higher in Normal (Supplementary  Table S4 ). Trophectoderm from Obese had an elevated LysoPI. Trophectoderm from Normal had two unknown mass peaks that were elevated, while trophectoderm from Obese had one elevated unknown mass peak (Supplementary Table S5) .
When compared to Normal, endometrial tissue from Obese tended to have greater relative concentrations of lactate (P = 0.10) and one putative oxoglutarate (P = 0.06), while a monosaccharide (P < 0.05) was lower and ethanolamine (P = 0.08) and uric acid (P = 0.10) tended to be lower (Supplementary Table S6 ).
Discussion
Pregravid obesity has been associated with reduced fertility, complications during pregnancy, and reduced fetal viability in woman [32] . Infants born to obese mothers often demonstrate increased adiposity at birth and increased risk for developing obesity and metabolic syndrome later in life [33] . Maternal prepregnancy body mass index and trigylceride levels play a significant role in mediating excessive fetal growth [34] . In the USA, two-thirds of women are overweight or obese at the time of conception [35] leading to the potential that maternal obesity is significant factor perpetuating the overall obesity epidemic [36] . Rates of overweight and obese horses are similar to humans [37] and effects on offspring remain unknown. In the present study, we sought to determine the impact of maternal obesity prior to conception on the uterine environment and on preimplantation embryos derived from oocytes impacted by alterations in the follicular environment [3] . Values in bold are different (P < 0.05) or tend to be different (P < 0.1). The correction factor indicates expression at 10 X . * Data were log-transformed for analysis.
Similar to a previous study [3] , obese mares had or tended to have increased circulating insulin, leptin, triglycerides, and total cholesterol, and insulin sensitivity and responsiveness was decreased indicating metabolic disruptions. These metabolic perturbations could impact body composition of offspring. In women, prepregnant body mass index and elevated triglyceride levels are associated with increased neonatal birth weight [38] . High levels of triglyceride in maternal circulation, possibly facilitated by insulin resistance, creates a steep concentration gradient across the placenta, which can accelerate transport and deposition of triglyceride and free fatty acids in fetal tissues [39] . In addition to increased substrate availability, fetuses from women with gestational or type I diabetes also demonstrate changes in placental gene expression related to lipid transport pathways and synthesis [40, 41] . Our findings indicate that some of these changes are occurring prior to embryo fixation in the uterus. As early as day 8 after conception, embryos from obese mares tended to have an increased transcript abundance of fatty acid synthase (FASN) which is a mediator of de novo long-chain fatty Values in bold are different (P < 0.05) or tend to be different (P ≤ 0.1). The correction factor indicates expression at 10 X . * Data were log-transformed for analyses.
acid production and particularly of palmitate which is necessary for embryonic development [42] . This increase was significant by D16 in trophectoderm. Maternal obesity has been shown to alter FASN in the offspring of other species. In contrast to our findings, blastocysts from obese mice have decreased expression of FASN at 3.5 days of gestation [2] . However, in that study, two different inbred strains of mice were used for obese and nonobese animals; therefore, the difference could be related to factors other than obesity. Alternatively, at 135 days of gestation, fetuses from obese ewes have an increase in FASN transcript in perirenal, pericardial, and adipose tissues [43] . Term infants born to women with high cholesterol and gestational diabetes mellitus have elevated FASN protein in placental tissue [41] . This is similar to the obese mares in our study, which were not diabetic; however, they had elevated cholesterol, reduced insulin sensitivity, and elevated serum insulin. In mice, insulin stimulates the rate of synthesis of FASN protein at the level of transcription of the FASN gene [44] , and FASN protein is primarily regulated at gene transcription [45] . This suggests that our findings of increased transcript abundance are likely resulting in increased protein. In addition to alterations in FASN, two genes involved in lipid transport were different in membranes of D16 embryos from normal and obese mares. Transcript abundance of solute carrier family 27 (SLC27A1), also known as fatty acid transport proteins (FATP), was increased in the D16 trophectoderm from Obese. Increased placental mRNA expression of SLC27A1 is also found in cotyledonary tissue from midgestation placentas in overweight ewes [46] . Overexpression of SLC27As in adipocytes increases rates of fatty acid internalization by cells [47] ; however, their roles within the placenta are not fully understood. In contrast, there was decreased transcript abundance of cluster of differentiation 36 (CD36) in both the D16 embryonic disc and trophectoderm from obese mares, which is in opposition to findings in cotyledonary tissue in sheep [46] and human placentas at term [48] . The apparent contradiction in findings could reflect differences in developmental stage and/or tissue (differentiated placental tissue versus undifferentiated trophectoderm). Regardless, in addition to increased long-chain fatty acid synthesis, there were alterations in gene expression associated with fatty acid transport in D16 trophectoderm from Obese. While there is certainly an influence of placental uptake of lipids, our study indicates that alterations associated with maternal weight in lipid homeostasis occur in the embryo and could be impacted by the oocyte or its follicular environment.
While trophectoderm had more alterations in the transcript abundance of genes related to lipid homeostasis, embryonic discs had more differences in the lipid fingerprint as determined by MALDI. Interestingly, more lipids were present at higher levels in D8 and D16 embryos from Normal when compared to Obese. In particular, three lipids were increased or tended to be increased in Normal when compared to Obese in at least two sample types. Glycerophosphocholine (12:0) tended to be elevated in both embryonic discs and trophectoderm in D16 embryos from Normal. Additionally, in embryos from Normal, PI (32:5) was increased in embryonic discs and tended to be increased in D8 embryos, while PI (42:7) was increased in D8 embryos and tended to be elevated in trophectoderm of D16 embryos. Many of the elevated lipids, including those that were different across sample types, are important for cell membrane integrity or second messenger signaling which was consistent with our findings in oocytes [3] . Increased concentrations of PC, PI, PG, PS, and CDP-DG found in the embryos from Normal are indicative of phospholipid biosynthesis and signal transduction [49] . Whether or not embryos from Obese have impaired cell membrane integrity or signal transduction would warrant further study. We did not observe elevated triglycerides in embryos from the obese mares, in contrast to our previous study of oocytes [3] . It is likely that much of the triglyceride in oocytes is used as an energy source during embryonic development [50] negating the difference in triglycerides in embryos.
In addition to alterations in lipid homeostasis, associations exist between maternal obesity and placental lipotoxicity, oxidative stress, and inflammation [1, 51] . In our study, trophectoderm from Obese had elevated transcript abundance of four genes indicating some level of oxidative stress. The first, glutathione peroxidase 1 (GPX1) is an antioxidant enzyme that catalyzes the reduction of hydroperoxides to water using glutathione as a reductant [52] . Full-term placentas from obese women have increased glutathione suggesting a compensatory mechanism to limit oxidative stress in the placenta [53] . Trophectoderm from D16 embryos from Obese had increased GPX1, which could be a response to oxidative stress; GPX1 was not evaluated for D8 or D16 embryonic discs in this study due to lower mRNA yields. Trophectoderm from Obese also had increased thioredoxin-2 (TXN2). Overexpression of TXN2 increases mitochondrial membrane potential and can have anti-apoptotic functions [54] . Embryos from Obese also tended to have elevated transcript abundance of DNA damage-inducible transcript 3 (DDIT3), also called C/EBP homologous protein or CHOP which can be associated with ER stress [55] and peroxiredoxin-2 (PRDX3), a mitochondrialspecific anti-oxidant [56] . The roles these molecules have in placental tissue, obesity, and metabolism remain unknown; however, our results indicate that some degree of oxidative, mitochondrial, and ER stress in D16 trophectoderm is associated with obesity in mares.
Altered increased DNA methylation has been linked to a challenged human maternal nutritional status in early pregnancy [18] . However, global DNA methylation is increased in monozygotic twins with decreased insulin sensitivity compared to their normoinsulinemic twin [57] . Therefore, we screened global DNA methylation in D16 embryos and endometrium. We found a tendency for higher hydroxymethylation in embryonic discs from normal-weight mares consistent with observations in human offspring conceived during seasons of decreased nutritional availability [17] . However, no determination was made regarding methylation or hydroxymethylation of the particular genes of interest in this study. When embryos were evaluated by sex, there was a tendency for methylation to be higher in female embryos from normal weight compared to obese mares; however, this tendency was not observed in male embryos. As there were not enough embryos for conclusive results (data not shown), this finding warrants further research to determine if there is a relationship between maternal obesity and DNA methylation to sex of the embryo. Further work should also be conducted to determine if observed changes in gene transcript abundance are related to epigenetic changes or alterations in cellular processes.
In our study, there appeared to be an association with maternal obesity and uterine inflammation. While obesity did not alter transcript abundance of proinflammatory cytokines in embryos, it did cause a marked increase in cytokine mRNA in mares' endometrium, a finding consistent with a previous study in rats [1] . Obese mares had a 3.8-to 4.5-fold increase in transcript abundance of the inflammatory cytokines (TNF and IL1B) in their endometrium. Inflammatory cytokines are important for maternal recognition and implantation (for review [58] ); however, increased exposure to cytokines can be problematic. Exposure to TNFα increased apoptosis in bovine embryos ≥9 cells [59] and the inner cell mass of mouse blastocysts [60] . Mouse blastocysts exposed to higher concentrations of cytokines are resorbed at an increased rate, and embryos that survive are significantly smaller [60] . Uteri from rats with maternal diabetes secreted more biologically active TNFα resulting in developmental deficiencies in preimplantation embryos compared to controls [61] . Another cytokine elevated in the endometrium of Obese was IL1B. Interleukin-1β is an important mediator of maternal-placental immunotolerance during implantation in several species [62] , and production of IL1B from the conceptus is important for signaling to the uterus for implantation [63] .While previous work has demonstrated elevated systemic IL1B and decreased insulin sensitivity in obese horses [7] , an effect of elevated uterine IL1B on the conceptus remains to be examined.
Increased inflammation could also be related to the significant reduction in transcript abundance of an inhibitor (NFKBIA) of nuclear factor kappa-light chain enhancer of activated B cells (NF-κB) in the endometrium of obese mares. Endometrium from Obese versus Normal had a 2.5-fold lower transcript abundance of NFKBIA. NF-κB is a transcription factor that when phosphorylated locates to the nucleus to positively regulate proinflammatory gene expression and is a probable contributor to the link between obesity and preeclampsia in women [64] . NFKBIA is important for inhibiting NF-κB by sequestering proteins in an inactive state in the cytoplasm and blocking NF-κB transcription factors from binding DNA, which is required for proper functioning [65] . Obese endometrium may have decreased inhibition of NF-κB, thereby possibly increasing the production of proinflammatory cytokines, especially TNFα and IL1β. Another potential contributor to increased inflammation in obese mares is the increased transcript abundance of ATF6 mRNA. Activating transcription factor 6 is another protein involved in the unfolded protein response during ER stress that promotes a general decrease in translation while allowing for selective translation of specific mRNAs [66] . Activation of ATF6 is a main factor responsible for release of TNF-α, IL-1β, and IL-6 [67] . Increased ATF6 signaling is associated with decreased cellular proliferation and could contribute to the impaired placental growth observed for pregnancies with fetal growth restriction and preeclampsia in women [68] .
Endometrium from Obese had decreased expression of IGF2 and IGFR2. Alterations in expression of IGF2 and DNA methylation of IGF2 have been previously associated with an increased risk of obesity and glucose intolerance (for review [69] ). However, the scope of most research evaluating the relationship between the IGF system and obesity is limited to evaluations of offspring, and further work investigating the maternal uterine environment needs to be conducted.
In conclusion, we observed that maternal obesity is associated with increased inflammation and ER stress in mares' endometrium. Maternal obesity altered transcript abundance in embryos, especially associated with the trophectoderm, for genes related to lipid homeostasis and mitochondrial, oxidative, and ER stress. This could predispose the developing placental tissues to altered lipid homeostasis and increased oxidative stress, which could be exacerbated by the proinflammatory uterine environment. Embryos from obese mares also decreased concentrations of lipids important for cell signaling and membrane integrity; however, the role, if any, these alterations have in the developing offspring remains unknown.
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